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Abstract
Objective: To identify the preoperative nutritional sta-
tus of women with gynecologic or breast cancer, in corre-
lation with disease site and staging as well as previous tre-
atments.
Subjects and methods: A cross-sectional study of 250
women evaluated by Body Mass Index (BMI) and Subjec-
tive Global Assessment (SGA). For data analysis, the chi-
square test was applied.
Results: Breast cancer was the most frequent cancer,
predominating in 56.2%. The median age of the patients
was 52 years. In about 57% of these women, the tumor
was restricted to clinical stages 0, I and II and 77% of the
women had not undergone any other oncologic treatment
prior to surgery. Subjective Global Assessment detected
76% of nourished women and 24% undernourished
women, while Body Mass Index identified 34% of nouris-
hed women, 3.6% undernourished women and 62.4%
overweight/obese women. A low level of diagnostic agree-
ment between normal nutrition and malnutrition by both
methods was observed (63.8%; kappa (95% CI) = 0.0884
(-0.07-0.24). No correlation between nutritional evalua-
tion and previous treatment and disease staging was
observed. Concerning anatomic site, it was subjectively
observed that women with cancer of the uterine corpus
were more malnourished than the rest (p = 0.02).
Conclusions: The findings suggest that a more careful
evaluation should be employed to identify preoperative
nutritional status in women with gynecologic or breast
cancer.
(Nutr Hosp. 2008;23:577-583)
Key words: Nutritional status. Gynecologic or breast can-
cer. Disease site. Staging. Obesity. Malnutrition.
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ESTADO NUTRITIVO DE PACIENTES CON
CÁNCER GINECOLÓGICO O DE MAMA
Resumen
Objetivo: Identificar el estado nutritivo preoperatorio
de mujeres con cáncer ginecológico o de mama, en corre-
lación con la localización de la enfermedad y su estadifi-
cación, así como de tratamientos previos.
Sujetos y métodos: Estudio transversal de 250 mujeres
evaluadas mediante Índice de masa corporal (IMC) y
Valoración global subjetiva (VGS). Se aplicó la prueba de
Chi cuadrado para el análisis de los datos.
Resultados: el cáncer de mama fue el tipo más fre-
cuente, predominando en el 56,2%. La edad media de las
pacientes fue de 52 años. En cerca del 57% de ellas, el
tumor estaba limitado a los estadios clínicos 0, I y II, y el
77% de ellas no habían sido sometidas a ningún otro tra-
tamiento oncológico antes de la cirugía. La valoración
global subjetiva detectó un 76% de las mujeres bien
nutridas y 24% malnutridas, mientras que el Índice de
masa corporal identificó un 34% de las mujeres bien
nutridas, un 3,6% de ellas malnutridas, y un 62,4% de
mujeres con sobrepeso/obesidad. Se observó un nivel bajó
de concordancia para nutrición normal y malnutrición
entre ambos métodos (63,8%; kappa (IC 95%) = 0,0884 
(-0,07-0,24). No se observó ninguna correlación entre la
evaluación nutricional y tratamiento previo o estadifica-
ción de la enfermedad. Con respecto a la localización ana-
tómica, se observó subjetivamente que las mujeres con
cáncer del cuerpo del útero presentaban mayor desnutri-
ción que el resto (p = 0,02). 
Conclusiones: Los hallazgos sugieren que se debería
realizar una evaluación más minuciosa para identificar el
estado nutritivo de las mujeres con cáncer ginecológico o
de mama.
(Nutr Hosp. 2008;23:577-583)
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In Brazil, the incidence of cancer was 470.000 new
cases in 2006 and the disease was more frequent among
women. The Brazilian reality is similar to that found in
the rest of the world. According to WHO, the estimated
number of new cancer cases will rise from 10 million
diagnosed in 2000 to 15 million in 2020.1,2
Estimates of the number of new cancer cases for
2006 in the southeast of Brazil suggest that the most
frequent cancer site is the breast, followed by the pros-
tate, colon and rectum, lungs/trachea/bronchi, sto-
mach, uterine cervix and other sites.1 In the State of São
Paulo, cancer is the second cause of death, correspon-
ding to 55% in men against 45% in women. Gynecolo-
gic and breast tumors are highlighted in women. In
2001-2002, both types of tumor accounted for about
31% of the total number of deaths, with a crude rate of
14.7 for the breast, 4.31 for the uterus, 3.7 for the ute-
rine corpus and 3.4 for the ovary per 100,000 inhabi-
tants.3
Between 1979 and 2003, the mortality rate due to
cancer increased 30% in Brazil and federal government
expenses with high complexity oncologic care increa-
sed 103% between 2000 and 2005.1 It must be cons-
tantly remembered that management of cancer patients
is very complex. Treatment involves multiple aspects 
—physical, psychological, social, cultural, spiritual
and economic. A holistic view of the patient and a mul-
tidisciplinary approach are mandatory. Along with this
ethical view of the human being, it is necessary to con-
sider the specificity of oncologic treatment. Surgery,
radiotherapy and/or chemotherapy are the mainstay of
cancer treatment.4
About 85% of cancer patients are at nutritional risk
or develop malnutrition due to the disease or its treat-
ment.5 The incidence of malnutrition in this specific
group is 30 to 50%.6-8 The oncologic patient often
undergoes several surgical procedures and nutritional
status is usually altered during hospitalization, resul-
ting in a worse prognosis.8 The association between
cancer and malnutrition has many consequences, inclu-
ding increased risk of infection, increased length of
hospitalization, poor wound healing, reduction in mus-
cle function and its consequences, thus affecting res-
ponse to therapy.5,8-11
In Brazil, the incidence of malnutrition was evalua-
ted by the Brazilian Survey of Nutritional Assessment
(IBRANUTRI) of the Brazilian Society of Parenteral
and Enteral Nutrition (SBNPE) in 4,000 patients from
25 public institutions in 13 states, using the method of
Subjective Global Assessment (SGA). It identified
20.1% of patients with cancer. Of these, 66.4% had
malnutrition, which was moderate in 45.1% and severe
in 21.3%.12,13
Nutritional assessment is the first step in identifying
and treating malnutrition and should be a part of pretre-
atment routine.5,8,14,15 However, the ideal method for this
evaluation has yet to be established, an association of
various indicators is required to improve the accuracy
of nutritional diagnosis.16
Some nutritional parameters such as Prognostic
Nutritional Indixs, serum albumin, total protein, trans-
ferrin, haemoglobin and anthropometric measurements
including weight have been used to assess the nutritio-
nal status in gynecological cancer patients.17,18 The sub-
jective global assessment is a validated nutritional ins-
trument tool that is commonly used to assess
nutritional status in patients who have a number of dif-
ferent conditions.19
Among the methods used, Body Mass Index (BMI)
and Subjective Global Assessment (SGA) are high-
lighted. BMI is a simple, cost-effective method, used
for calculating total body composition. The drawbacks
are dehydration, ascitis, edema and muscle hyper-
trophy that can mask real body weight.20
SGA is a subjective and easily applied method. It
assesses the clinical history of the patient, modification
of functional capacity, degree of metabolic stress and
modifications at physical examination.15,17,21 SGA has
been considered a very efficient method for nutritional
evaluation, since its results are equivalent to those
obtained by objective methods.17,22
Thus, the current study was aimed at identifying the
preoperative nutritional profile of women with gyneco-
logic and breast cancer using the two methods cited, in
correlation with location and staging of the disease as
well as previous oncologic therapies.
Patients and methods
A cross-sectional study of 250 women admitted for
surgery due to gynecologic or breast cancer was con-
ducted in CAISM/UNICAMP from august 2003 to
april 2005. Sample size was based on prevalence of
66.4% of malnourished patients hospitalized with
cancer7, considering a significance level of 5% and a
sample error of 6% (estimated 95% CI of 60.4% to
72.4%).
This study was approved by the Research Ethics
Committee in the School of Medicine-UNICAMP,
following the precepts of the Declaration of Helsinke.
All women signed the written informed consent term
(WICT), and none refused to participate in the study.
Included in the study were patients admitted for pri-
mary surgical cancer treatment of the breast, ovary,
vulva, uterine cervix and corpus, confirmed by histo-
pathology exam. Patients with other associated diagno-
ses, including non-gynecologic primary cancer, AIDS,
renal or hepatic failure were excluded from the study.
After signing a written informed consent term
(WICT), the patient or her companion was interviewed
about age, school education, usual weight, previous
treatments (chemotherapy and/or radiotherapy), and
associated diseases such as hypertension and/or diabe-
tes using a brief semi-structured questionnaire, admi-
nistered by the researcher.
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Nutritional status was evaluated on the basis of
SGA23 and BMI calculation.24 For BMI, medical charts
containing information on weight and height were
used. When height and weight were not included in the
charts, measurements were taken on the day of the
interview, using a calibrated scale (Filizola) with a
capacity of 150 kg and accuracy of 100 grams. The
woman had to stand at the center of the scale base,
barefoot and wearing light clothes. To measure height,
a stadiometer attached to a scale was used, with the
woman standing, barefoot, with her heels close toget-
her, back straight and arms stretched along the body. 
BMI was defined as weight (in kilograms) divided
by the square of the height (in meters).24 The cut-off
points in kg/m2, considered for nutritional diagnosis
were: < 16.0 kg/m2 - grade III malnutrition (severe);
16.0 to 16.99 kg/m2 – grade II malnutrition (moderate);
17.0 to 18.49 kg/m2 - grade I malnutrition (mild); 18.5
to 24.99 kg/m2 - nourished; 25.0 to 29.99 kg/m2 - over-
weight; 30.0 to 34.99 kg/m2 - grade I obesity (mild);
35.0 to 39.99 kg/m2 - grade II obesity (moderate); and 
≥ 40.0 kg/m2 - grade III obesity (severe).24
The SGA protocol was created by Detsky (1984) and
modified by Garavel (1988). It is a clinical technique
that rapidly informs about nutritional status by comple-
tion of a questionnaire including anamnesis and physi-
cal examination. Anamnesis assesses the percentage of
weight loss in the past six months, changes in dietary
patterns, gastrintestinal (GI) symptoms, loss of vitality
or physical functional capacity and a decreased feeling
of well-being. Physical examination investigates the
presence or absence of malnutrition by palpation of
adipose tissue, volume of muscle mass and presence of
edema. Nutritional status is defined by the total sum of
partial points and is thus classified: normal nutrition ≤
7; mild malnutrition: > 7 to 17; moderate malnutrition:
> 17 to 22; and severe malnutrition: > 22 points.23
Data was typed in duplicate. For statistical analysis,
the chi-square test with Yates correction, with SAS
8.210 software was used. The agreement between the
diagnoses of normal nutrition and malnutrition was
calculated by both methods using kappa coefficient
and its 95% confidence interval. The significance level
of 5% was adopted. 
Results
Among the 250 patients evaluated, the most frequent
anatomical site of cancer was the breast (56.4%) follo-
wed by the uterine cervix (about 30% of the cases). A
significantly lower frequency of cancer of the uterine
corpus, ovary and vulva was found. The median age of
the patients was 52 years, ranging from 15 to 90 years,
and 55.2% of the women were 40-59 years of age at the
time of assessment. About 80% had complete Junior
High School education and only 7% had complete hig-
her education. Forty per cent of the women evaluated
had clinical comorbidity associated with underlying
oncologic diseases. The most frequent comorbid con-
ditions were diabetes, chronic arterial hypertension and
both conditions associated (table I).
About 57% of the patients were in clinical stages 0, I
and II (disease restricted to primary organ site), and
less than 25% had undergone chemotherapy and/or
radiotherapy prior to surgical indication. In 48 patients,
the surgery proposed was minor (conization, uterine
curettage, biopsy or breast resection, vulva biopsy),
while 103 patients had surgery of medium complexity
(radical mastectomy, quadrantectomy with axillary
dissection) and 99 patients had major surgery (Wert-
heim-Meigs, radical vulvectomy, laparotomy for sta-
ging of ovarian or endometrial cancer) (table I). 
The median nutritional evaluation by BMI was 26.8
kg/m2 (ranging from 16.2 to 58.5 kg/m2). Thirty-four
percent (34%) of the women were considered nouris-
hed, 3.2% had mild nutrition 0.4% had moderate mal-
nutrition, 41.2% were overweight and 21.2% were
obese (15.2% grade I obesity, 3.6% grade II obesity
and 2.4% grade III obesity) (table II). According to the
SGA technique, more than two-thirds of the patients
(76%) were classified as nourished and the others as
malnourished. Of these, 23.6% were mildly malnouris-
hed or at nutritional risk and 0.4% were moderately
malnourished (table II). 
The level of agreement between patients diagnosed
as nourished or undernourished by both methods (n =
94) was 63.8%, with a kappa coefficient of 0.0884 and
95%CI from -0.07 to 0.24. Among the 156 patients
classified as overweight or obese by BMI, 25 (16%)
were considered undernourished by SGA.
More than 60% of the women had reported no
weight loss in the past six months before surgical
admission. Only 19% reported a change in diet sponta-
neous, 77% of them were on a low calorie diet. It was
verified that 25% of the women had ankle edema, 2%
had sacral edema and about 17% had ascitis. Loss of
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subcutaneous fat was observed in 22% and skeletal
muscle depletion in 20% of the women. However,
regarding physical capacity, 67% of the women repor-
ted normal functioning. Regarding GI symptoms,
63.6% reported a lack of any symptom. Conversely,
15.6% had dysfagia and/or vomiting and/or nausea or
the three symptoms associated, and 20.8% reported
feeling anorexia and/or bloating and/or diarrhea or the
association of these symptoms (table III).
According to SGA classification, women with can-
cer of the uterine body were significantly more under-
nourished than those with other types of tumor (p =
0.02). Meanwhile, according to BMI evaluation, there
was no association between nutritional status and can-
cer site (table IV).
The nutritional status of patients evaluated both by
BMI and SGA was not influenced by disease staging 
(p = 0.2419 and p = 0.1288, respectively) in all types of
cancer, as well as with the oncologic therapies performed
prior to surgery (p = 0.2245 and p = 0.7048, respectively). 
Discussion
There has been growing interest in malnutrition
among surgical patients in recent years. It is well-
known that it plays a role in the development of posto-
perative complications. This is particularly true for
oncologic patients. Apart from a higher frequency of
malnutrition, these patients are candidates for aggres-
sive and mutilating procedures.5,10,12,18,22,25-27
Diagnosis of malnutrition is vitally important for
patient outcome and treatment. The sooner it can be
identified and/or corrected, preventing nutritional
deficiencies, the sooner it can be treated.5,8,27-30 Malnu-
trition has a prognostic value regarding morbidity: a
higher risk of pressure ulcers, surgical complications,
infections, dependence on mechanical ventilation and
prolonged hospital stays.8,21 Conversely, obesity pre-
disposes to the development of clinical complica-
tions, including arterial hypertension, higher surgical
risk, and dehiscence in the postoperative period, insu-
line resistance, sleep apnea and respiratory disor-
ders.11,31,32
Removal of the primary tumor, and therefore, the
underlying cause of malnutrition create adequate con-
ditions for utilizing the nutrients offered. The patient
also requires appropriate conditions to undergo treat-
ment, be it surgical, chemotherapy or radiotherapy
with the lowest risk of complications.7,8,33
The most adequate manner to perform nutritional
evaluation is highly controversial, since no method is
considered the “gold standard”. The ideal would be to
use a rapid, low-cost, non-invasive method. Simultane-
ously, it would have to be of high sensitivity and speci-
ficity. We sought a simple methodology; capable of
reflecting the reality of a Brazilian public university
hospital that has limited resources for more specific
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Normal nutrition 190 76.0
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Any GI symptoms 159 63.6
Dysfagia and/or vomiting and/or nausea 39 15.6
Anorexia and/or bloating and/or diarrhea 52 20.8
Weight loss
None 153 62.0
≤ 10% 74 29.0
> 10% 23 9.0















Mild depletion 46 18.4
Severe depletion 9 3.6
Striated skeletal muscle
Normal 200 80.0
Mild depletion 42 16.8
Severe depletion 8 3.2
Physical functioning capacity
Normal 168 67.2
Below normal 81 32.4
Bedridden 1 0.4
nutritional evaluations in its daily routine. This study
was based on a study of IBRANUTRI,12 using the SGA
technique for nutritional evaluation. SGA is a subjec-
tive method, associated with BMI, which is an objec-
tive method.
SGA is an easy, low-cost and non-invasive method.
It can be performed in a few minutes at the patient’s
bedside.13,16,17,27 The method is widely accepted in clini-
cal practice for the surgical patient and may be applied
by any healthcare professional (nursing, medical or
nutrition). The average time spent applying the ques-
tionnaire and physical examination is five to fifteen
minutes.5,17,30,34
BMI is a very common, easy, practical, and virtually
inexpensive method. Data on weight and height are
normally in the medical chart of the patient. However,
it does not detect malnutrition with absolute accuracy,
since it does not appraise recent weight loss, changes in
diet, GI symptoms and clinical parameters. It is a good
method to evaluate young individuals or healthy
adults. Body weight may be masked in cancer patients
and hydration status influences body composition.5,16
Other methods for nutritional evaluation include
anthropometric measures such as skinfold thickness,
measurements of arm and pulse circumference; and
evaluations through laboratory tests and bioelectric
impedance analysis (BIA).21 The professionals who
apply these methods require more specialization, more
time available, increasing extra costs to the public
health system. Since the allotted budget of our health-
care service is limited, we did not adopt these methods
for our nutritional evaluations. 
SGA detected a frequency of 24% of malnutrition.
Virtually all women had mild malnutrition or were at
nutritional risk. Only 0.6% was severely undernouris-
hed by SGA, while 3.6% were undernourished by
BMI. Furthermore, the level of agreement between
both methods for diagnosis of normal nutrition and
malnutrition was low (63.8%; kappa (95% CI) =
0.0884 (-0.07-0.24), inferring that the parameters used
in each method are different and not always comple-
mentary.
Even small amounts of weight loss (less than 5% of
body weight) may significantly worsen the progno-
sis.35,36 Among those interviewed, it was observed that
29.6% had lost 10% or less of weight, while 19.6% had
lost more than 10%, in relation to usual weight. Loss of
weight should raise the alert for patient prognosis,
because recent weight loss (past six months) puts
patients at nutritional risk. It would have been possible
to detect how much this represented in terms of protein
loss, if serum albumin had been performed in these
women. Nourished, overweight and obese women, as
well as protein depletion could then be detected.
At first, BMI seems to be the most efficient method
for diagnosing obesity. In our study, it detected 21.2%
of obese and 41.2% of overweight women. Meanwhile,
SGA does not distinguish between overweight and
obesity, demonstrating that a subjective evaluation
alone would not be an efficient method for nutritional
evaluation in this specific group of women. However,
16% of overweight or obese women by BMI were con-
sidered undernourished by SGA.
Ideally, SGA and BMI should not be applied alone
in a nutritional evaluation. These methods should
accompany other objective parameters, e.g. measure-
ments of skinfold thickness and midarm circumfe-
rence, laboratory tests (serum levels of albumin, preal-
bumin, iron, ferritin, etc.). These parameters provide
real measurements of protein loss and may detect
women at nutritional risk and/or malnutrition.5 Thus, a
single method of evaluation is inadequate and limited.
Laky et al. (2007), in a SGA of 145 patients with
gynecologic and breast cancer verified that 80% of the
women were nourished and 20% were undernourished.
Of these undernourished women, 67% had ovarian








N % N % N % N % N %
BMI
Malnutrition 3 2.1 1 7.1 1 7.1 3 4.5 1 7.1
Normal nutrition 51 36.4 2 14.3 6 42.9 21 31.3 6 42.9
Overweight 60 42.9 8 57.1 5 35.7 25 37.3 3 21.4 0.992**
Obesity 26 18.6 3 21.4 2 14.3 18 26.9 4 28.6
SGA
Malnutrition 34 24.3 4 28.6 4 28.6 10 14.9 8 57.1 0.0213*
Normal nutrition 106 75.7 10 71.4 10 71.4 57 85.1 6 42.9
Total 140 56.2 14 5.6 14 5.6 67 26.9 14 5.6
*Chi-square test.
**Chi-square test with Yates correction.
cancer.37 Our results were very similar to those found
by those authors, apart from the incidence of ovarian
cancer, which was 28.6% in our study. In the current
study, a low incidence of malnutrition (24%) occurred
because breast tumor was the most frequent type of
cancer (56.4%), followed by cervical cancer (26.8%),
while ovarian cancer accounted for only 5.6% of the
cases. According to Gómez Candela (2003) and Laky
(2007), ovarian cancer compromised their patients
most seriously. In the current study, SGA detected
57.1% of malnutrition in cases of cancer of the uterine
corpus, 28.6% in ovarian and/or vulvar cancer, 24.3%
in breast cancer and 14.9% in cervical cancer, showing
results that are different from those in other publica-
tions, where ovarian cancer is predominant in cases of
malnutrition.22,37
Therefore, evaluation of candidates for surgery of
gynecologic or breast cancer is necessary, as demons-
trated in our study and in those of other authors.18,22,37-39
Results have shown that women who had stage 0, I and
II cancer, regardless of cancer type and I were nouris-
hed, despite a recent history of weight loss. It is clear
that nutritional evaluation and nutritional therapy must
be begun before cancer progression.38 Bozzetti et al.
(1982) and Tunca (1983) also found an association bet-
ween malnutrition and cancer site and staging. The
more advanced the tumor, the more malnourished the
patient.38,39
Evaluating the nutritional status of women admitted
for surgery, we were faced with the most frequent can-
cer among them:1 breast cancer with 141 cases against
109 cases of other types of gynecologic cancer. This
rate made our sample less susceptible to malnutrition,
since breast cancer has a direct relationship with incre-
ased weight and/or obesity.40-42
Minor surgeries and those of medium complexity
accounted for 60.4%, since 56.8% of the women were
in stages 0, I, and II of the disease. The majority of
patients (76.8%) did not need previous radiotherapy
and/or chemotherapy treatment, constituting a less
aggravating picture for the women studied.
The current study could have obtained more clarif-
ying results if a similar number of cases of all cancer
types were determined, or if it had included any other
objective nutritional evaluation with some laboratory
tests such as albumin. Albumin represents a parameter
for protein loss, appraising visceral protein reserve.
Furthermore, it is important in the analysis of slow and
progressive conditions of tumor cachexia. Patients
with low albumin levels have been undernourished for
a considerable time, long enough to compromise hepa-
tic cellular mass. Furthermore, serum albumin level is
correlated with the appearance of postoperative com-
plications.10
In an attempt to value nutritional intervention to pre-
vent postoperative complications and consequently
reduce hospitalization costs, government regulation
number 272 of the Sanitary Vigilance Office of the
Ministry of Health dating from april 8, 1998 was desig-
ned with normative guidelines for all public and private
hospitals. A Nutritional Therapy Multidisciplinary
Team was organized and composed of at least one phy-
sician, a pharmacist, a nurse and a nutritionist qualified
to practice Nutritional Therapy assessment.43
It is necessary for the healthcare system (healthcare
professionals and hospital administrators) to unders-
tand that diagnosing overweight and/or obesity, as well
as malnutrition in the oncologic patient prior to surgi-
cal intervention, means treating these patients correctly
and reverting possible surgical and clinical complica-
tions. The length of hospitalization is reduced, increa-
sing turnover of hospital beds, lowering costs due to
hospital admissions, increasing the therapeutic res-
ponse and consequently improving the prognosis.12,15
Conclusions
According to SGA, 24% of the patients had malnutri-
tion, while only 3.6% were considered undernourished
by BMI. There was a low level of agreement between the
diagnosis of normal nutrition and malnutrition by both
methods (63.8%).
The highest prevalence of malnutrition was found in
women with uterine body cancer, according to SGA.
There was no correlation between nutritional status and
disease stage and other oncologic treatments before
surgery.
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